乳腺癌相关骨质疏松症的发病机制及防治  

Pathogenesis and Prevention of Breast Cancer Associated Osteoporosis

作　　者：李红[1] 孔令泉[1] 吴凯南[1] LI Hong;KONG Ling-quan;WU Kai-nan(Department of Endocrine Breast Surgery,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China)

机构地区：[1]重庆医科大学附属第一医院内分泌乳腺外科,重庆400016

出　　处：《医学信息》2020年第7期36-39,共4页Journal of Medical Information

摘　　要：近年来乳腺癌筛查手段和综合治疗水平不断提高,有效延长了患者的生存期。鉴于其总体预后良好,优化乳腺癌患者的长期生存质量至关重要。乳腺癌相关骨质疏松症是其中的一个研究热点,该病威胁着中、老年人,尤其是绝经后女性的身体健康,但是目前骨质疏松症的发现和诊断率都很低,常因无明显症状和体征被忽略,很多患者是在骨折时才发现有骨质疏松。本文从乳腺癌骨质疏松症的发生机制、评估手段、治疗方法进行综述。In recent years,breast cancer screening methods and comprehensive treatment have been continuously improved,effectively prolonging the survival period of patients.Given its good overall prognosis,it is crucial to optimize the long-term quality of life of breast cancer patients.Breast cancer-related osteoporosis is one of the research hot spots.The disease threatens the health of middle-aged and elderly people,especially post-menopausal women.However,the current rate of osteoporosis discovery and diagnosis is very low obvious symptoms and signs are ignored,and many patients only discover osteoporosis when they fracture.This article reviews the pathogenesis,evaluation methods and treatment methods of breast cancer osteoporosis.

关 键 词：乳腺癌 乳腺癌伴随疾病 骨质疏松症 骨密度 

分 类 号：R273[医药卫生—中西医结合]